Creating a new method to improve heart cell repair after heart attacks
Engineering a cross-linked cellular network for cardiac repair
This study is testing a new way to help heal heart tissue after a heart attack by using a special scaffold that holds and delivers healing cells better, which could lead to more effective treatments for heart damage.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10901860 on NIH RePORTER |
What this research studies
This research focuses on enhancing the repair of heart tissue following a heart attack by developing a unique scaffold that allows for better retention and delivery of therapeutic cells. The approach involves using specially designed proteins to create a network of cells that can capture and hold additional therapeutic doses over time. This method aims to improve the effectiveness of cell therapy by ensuring that more cells remain at the injury site, thereby maximizing healing potential. Patients may benefit from a more effective treatment for heart damage through this innovative delivery system.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced a myocardial infarction and are seeking advanced therapeutic options for heart repair.
Not a fit: Patients with non-cardiac conditions or those who have not experienced a heart attack may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for heart repair, improving recovery outcomes for patients who have suffered heart attacks.
How similar studies have performed: While the approach of using engineered cellular scaffolds is innovative, similar strategies in regenerative medicine have shown promise in other contexts, suggesting potential for success in this area as well.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Nguyen, Juliane — Univ of North Carolina Chapel Hill
- Study coordinator: Nguyen, Juliane
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.